Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Nov 1, 2022--
The "Diabetes Injection Pens Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030" report has been added to ResearchAndMarkets.com's offering.
The purpose of this research study titled 'Diabetes Injection Pens Market - Growth, Future Prospects, and Competitive Analysis, 2022 - 2030' is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global diabetes injection pens market. This report presents and analyzes the major trends prevalent in the global diabetes injection pens market and the market size and forecast.
This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global diabetes injection pens market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the diabetes injection pens market.
Injection pens are observed to be administered in both type I and type II patients. Between these patient groups, type II diabetes acquires the larger revenue share due to large patient population belonging to this condition. In addition, since type II diabetes majorly occurs in adult individuals, rational insulin administration through injection pens is highly prevalent.
However, increasing patient base of children suffering with type II diabetes presents lucrative penetration opportunity to the diabetes injection pens manufacturers. Based on injection forms, this market is categorized into disposable and reusable injection pens. Both disposable and reusable forms of diabetes injection pens are nearly equally used across patients worldwide. However, it is observed that reusable pens are more preferred in developed markets. It is anticipated that the same trend will continue through the forecast period, with higher preference for disposable injection forms being more preferred in developing economies.
Geographically, the global diabetes injection pens market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Among the considered regional markets, North America and Europe together occupy the largest revenue share of the global diabetes injection pens market. In North America and globally, the United States captures the largest revenue share. The dominance of United States is attributed to large diabetic population, better reimbursement system and healthcare awareness about treatment and management of diabetes. The Europe market, however, is observed to be saturated and will undergo average growth rate. Furthermore, Asia Pacific is anticipated to be the fastest progressing regional market for diabetes injection pens. Growing awareness and increased ability of patients to pay for advanced medicine are the key driving factors for Asia Pacific diabetes injection pens market.
Market Segmentation
Indication
Product
Form
Key Questions Answered in this report
Key Topics Covered:
1. Preface
2. Executive Summary
3. Diabetes Injection Pens Market: Business Outlook & Market Dynamics
4. Diabetes Injection Pens Market: By Indication, 2020-2030, USD (Million)
5. Diabetes Injection Pens Market: By Product, 2020-2030, USD (Million)
6. Diabetes Injection Pens Market: By Form, 2020-2030, USD (Million)
7. North America Diabetes Injection Pens Market, 2020-2030, USD (Million)
8. UK and European Union Diabetes Injection Pens Market, 2020-2030, USD (Million)
9. Asia Pacific Diabetes Injection Pens Market, 2020-2030, USD (Million)
10. Latin America Diabetes Injection Pens Market, 2020-2030, USD (Million)
11. Middle East and Africa Diabetes Injection Pens Market, 2020-2030, USD (Million)
12. Company Profile
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/k4x3iu
View source version on businesswire.com:https://www.businesswire.com/news/home/20221101005861/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: DIABETES HEALTH MEDICAL DEVICES
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 11/01/2022 08:25 AM/DISC: 11/01/2022 08:26 AM
http://www.businesswire.com/news/home/20221101005861/en